Claritin and Irbesartan drug interactions for women aged 60+ (a phase IV clinical study of FDA data)

Summary:

Drug interactions are found for women aged 60+ who take Claritin (loratadine) and Irbesartan (irbesartan) together. We list drug interactions by the duration when the drugs are taken. This phase IV study is created by eHealthMe based on reports of 49 people from the FDA, and is updated regularly.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 22, 2026

49 women aged 60+ who take Claritin, Irbesartan and have drug interactions are studied.


What is Claritin?

Claritin has active ingredients of loratadine. It is often used in allergies. eHealthMe is studying from 77,316 Claritin users. Check the latest studies of Claritin.

What is Irbesartan?

Irbesartan has active ingredients of irbesartan. It is often used in high blood pressure. eHealthMe is studying from 36,414 Irbesartan users. Check the latest studies of Irbesartan.

Number of reports submitted per year:

Claritin and Irbesartan drug interactions in women aged 60+.

Most common drug interactions over time *:

< 1 month:

  1. Fall
  2. Adverse event
  3. Constipation
  4. Cough
  5. Device failure
  6. Diverticulum (out pouching of a hollow (or a fluid-filled) structure in the body)
  7. Dyspnoea (difficult or laboured respiration)
  8. Endometriosis (appearance of endometrial tissue outside the uterus and causing pelvic pain)
  9. Eyelid ptosis (falling of the upper or lower eyelid)
  10. Facet joint syndrome (problem with movement of the facet joints of the spine)

1 - 6 months:

n/a

6 - 12 months:

n/a

1 - 2 years:

n/a

2 - 5 years:

n/a

5 - 10 years:

n/a

10+ years:

n/a

not specified:

  1. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  2. Hepatitis (inflammation of the liver)
  3. Hypoalbuminaemia (levels of albumin in blood serum are abnormally low)
  4. Infusion site bruising
  5. Infusion site swelling
  6. Joint swelling
  7. Malaise (a feeling of general discomfort or uneasiness)
  8. Nasopharyngitis (inflammation of the nasopharynx)
  9. Platelet count increased
  10. Productive cough

* Approximation only. Some reports may have incomplete information.

Do you take Claritin and Irbesartan?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.



Related studies:

How the study uses the data?

The study is based on (applicable) gender, age, loratadine and irbesartan (the active ingredients of Claritin and Irbesartan, respectively), and Claritin and Irbesartan (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: